Search
NRX Pharmaceuticals Inc
NRXPAdd to Watchlist
3.320USD
-0.070-2.06%
Close 09-18 16:00（ET）
144.58MMarket Cap
LossP/E TTM
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D
Today
-2.06%
5 Days
-2.35%
1 Month
-3.49%
6 Months
+74.74%
Year to Date
+22.51%
1 Year
+11.41%
Key Figures
3.380Open
3.420High
60.55KVolume
LossP/E TTM
1.85P/E Dynamic
--Dividend TTM
0.14%Turnover Ratio
3.390Prev. Close
3.310Low
203.38KTurnover
LossP/E Static
-850.46P/B
0.00%Div Yield TTM
-251.78%ROA
5.05552wk High
0.08Volume Ratio
-25.13MNet Profit
43.16MShares
-1.0457EPS TTM
2.12Beta
-682.81%ROE
1.62052wk Low
2.95%Amplitude
32.70%Gross Margin
144.58MMarket Cap
-4.18Reward/Risk
5.48%Risk Rate
NRX Pharmaceuticals Inc's Score
0.09vs previous score
Forecast8.40
Financial Health5.97
Technical4.21
Valuation Dimensions9.82
Institutional Confidence3.00
Risk Assessment4.02
Media Coverage
Coverage Level
Very Low
Very High
Positive
Analyst Rating
NRX Pharmaceuticals Inc Technical Analysis
Technical Indicators
Strong sell
Summary
Sell
Moving Average
Strong sell
NRX Pharmaceuticals Inc Latest Earnings Call Transcripts
NRx Pharmaceuticals (NRXP) Q2 2026 Earnings Call: ANDA Progress and $26.7M Cash
NRx Pharmaceuticals’ Q2 2026 earnings call covered $26.7 million in cash, KETAFREE FDA progress, the SPARC-TMS trial and GeNeuro’s ALS program.
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
-0.44/0.06
Revenue / Forecast
1.10M/16.56M
NRX Pharmaceuticals Inc Profile
SectorBiotechnology & Medical Research
Ticker SymbolNRXP
Number of employees0
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| Anson Funds Management LP. | 9.21% |
| B Group, Inc. | 9.07% |
| Javitt (Jonathan C) | 4.59% |
| Vanguard Capital Management, LLC | 3.51% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor | 16.89% |
| Hedge Fund | 9.31% |
| Individual Investor | 5.39% |
| Corporation | 2.91% |
Related Instruments
+0.04%
-0.09%
-0.04%
-0.02%
-0.19%
-0.39%
+1.55%
-0.52%
+0.07%
+0.12%
+0.35%
-1.55%
-1.65%
-1.53%
-0.56%
-0.58%
-0.55%
-2.55%
-0.73%
-0.42%Popular Instruments
51734.000
-26.000 (-0.05%)
29664.700
+252.000 (+0.86%)
7659.100
+27.000 (+0.35%)
14420.000
+119.000 (+0.83%)
65079.000
+130.000 (+0.20%)
6230.800
-76.400 (-1.21%)
96.001
-1.985 (-2.03%)
336.130
-0.870 (-0.26%)
222.270
+2.930 (+1.34%)
4377.330
+36.350 (+0.84%)
FAQs
What is the current price of NRX Pharmaceuticals Inc (NRXP)?
The current price of NRX Pharmaceuticals Inc (NRXP) is 3.32.
What is the symbol of NRX Pharmaceuticals Inc?
The ticker symbol of NRX Pharmaceuticals Inc is NRXP.
What is the 52-week high of NRX Pharmaceuticals Inc?
The 52-week high of NRX Pharmaceuticals Inc is 5.05.
What is the 52-week low of NRX Pharmaceuticals Inc?
The 52-week low of NRX Pharmaceuticals Inc is 1.62.
What is the market capitalization of NRX Pharmaceuticals Inc?
The market capitalization of NRX Pharmaceuticals Inc is 144.58M.
Is NRX Pharmaceuticals Inc (NRXP) currently rated as Buy, Hold, or Sell?
According to analysts, NRX Pharmaceuticals Inc (NRXP) has an overall rating of Buy, with a price target of 38.25.
What is the Earnings Per Share (EPS TTM) of NRX Pharmaceuticals Inc (NRXP)?
The Earnings Per Share (EPS TTM) of NRX Pharmaceuticals Inc (NRXP) is -1.05.